IC-8 Apthera IOL New Enrollment Post Approval Study

Exclusion Criteria

• •Pharmacologically dilated pupil size less than 7.0 mm in the IC-8 Apthera IOL eye;
• •Irregular astigmatism in either eye;
• •History of retinal disease;
• •Active or recurrent anterior segment pathology;
• •Presence of ocular abnormalities;
• •Diagnosis of dry eye in which patients are unable to maintain eye comfort or adequate vision even with dry eye treatment;
• •Previous corneal or intraocular surgery, except cataract surgery;
• •History of ocular trauma or ocular conditions expected to require retinal laser treatment or other surgical intervention;
• •Acute, chronic or uncontrolled systemic disease that would, in the opinion of the investigator, confound the outcomes of the study;
• •Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with hormonal fluctuation that could lead to refractive changes and dry eye;
• •Concurrent participation or participation in any clinical trial up to 30 days prior to the first visit in the study.
• •Subjects who plan to be traveling, relocating or otherwise unavailable to attend any of the visits